TSBX — Turnstone Biologics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $54.81m
- -$23.03m
- $19.31m
Annual cashflow statement for Turnstone Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 33.3 | -30.8 | -55.2 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 5.47 | 13.8 | 4.17 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -85.7 | -58 | -17.9 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -45.6 | -71.1 | -66.2 |
| Capital Expenditures | -3.41 | -5.17 | -1.25 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0.058 | -9.76 | -26.8 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -3.35 | -14.9 | -28.1 |
| Financing Cash Flow Items | — | -2.81 | -0.898 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 80 | -2.66 | 77 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 31 | -88.7 | -17.2 |